ASSET | DATE | % RETURN |
---|---|---|
Sezzle Inc Common Stock (SEZL) | 11/7/2023 - 11/8/2024 | 4,250.56% |
LENZ Therapeutics (LENZ) | 11/7/2023 - 11/8/2024 | 2,061.08% |
Power Solutions International, Inc Common Stock (PSIX) | 11/7/2023 - 11/8/2024 | 882.46% |
Dogness International Corp Class A (DOGZ) | 11/7/2023 - 11/8/2024 | 863.38% |
Dave (DAVE) | 11/7/2023 - 11/8/2024 | 818.58% |
Root (ROOT) | 11/7/2023 - 11/8/2024 | 719.3% |
Terawulf (WULF) | 11/7/2023 - 11/8/2024 | 663.89% |
ASP Isotopes Inc Common Stock (ASPI) | 11/7/2023 - 11/8/2024 | 618.85% |
Capricor Therapeutics (CAPR) | 11/7/2023 - 11/8/2024 | 593.66% |
Sangamo Therapeutics (SGMO) | 11/7/2023 - 11/8/2024 | 572.13% |
Nano Nuclear Energy Inc Common Stock (NNE) | 11/7/2023 - 11/8/2024 | 533.89% |
Corvus Pharmaceuticals (CRVS) | 11/7/2023 - 11/8/2024 | 530% |
Porch (PRCH) | 11/7/2023 - 11/8/2024 | 420.11% |
Emergent Biosolutions (EBS) | 11/7/2023 - 11/8/2024 | 402.99% |
Neurogene (NGNE) | 11/7/2023 - 11/8/2024 | 388.61% |
Praxis Precision Medicines (PRAX) | 11/7/2023 - 11/8/2024 | 385.2% |
Grupo Supervielle (SUPV) | 11/7/2023 - 11/8/2024 | 383.56% |
Innodata (INOD) | 11/7/2023 - 11/8/2024 | 382.3% |
Silverback Therapeutics (SPRY) | 11/7/2023 - 11/8/2024 | 374.65% |
Nurix Therapeutics (NRIX) | 11/7/2023 - 11/8/2024 | 364.97% |
Arcutis Biotherapeutics (ARQT) | 11/7/2023 - 11/8/2024 | 362.39% |
Real Brokerage (REAX) | 11/7/2023 - 11/8/2024 | 360.99% |
Vera Therapeutics (VERA) | 11/7/2023 - 11/8/2024 | 358.87% |
Willis Lease Finance (WLFC) | 11/7/2023 - 11/8/2024 | 355.92% |
Hyliion (HYLN) | 11/7/2023 - 11/8/2024 | 347.62% |
Gathering data
Check back later